Sudden cardiac death: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
'''For patient information click [[{{PAGENAME}} (patient information)|here]]'''{{SI}}
'''For patient information click [[{{PAGENAME}} (patient information)|here]]'''{{SI}}
{{WikiDoc Cardiology Network Infobox}}
{{WikiDoc Cardiology Network Infobox}}
{{CMG}}
{{CMG}}

Revision as of 18:45, 8 July 2009

For patient information click here

WikiDoc Resources for Sudden cardiac death

Articles

Most recent articles on Sudden cardiac death

Most cited articles on Sudden cardiac death

Review articles on Sudden cardiac death

Articles on Sudden cardiac death in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Sudden cardiac death

Images of Sudden cardiac death

Photos of Sudden cardiac death

Podcasts & MP3s on Sudden cardiac death

Videos on Sudden cardiac death

Evidence Based Medicine

Cochrane Collaboration on Sudden cardiac death

Bandolier on Sudden cardiac death

TRIP on Sudden cardiac death

Clinical Trials

Ongoing Trials on Sudden cardiac death at Clinical Trials.gov

Trial results on Sudden cardiac death

Clinical Trials on Sudden cardiac death at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Sudden cardiac death

NICE Guidance on Sudden cardiac death

NHS PRODIGY Guidance

FDA on Sudden cardiac death

CDC on Sudden cardiac death

Books

Books on Sudden cardiac death

News

Sudden cardiac death in the news

Be alerted to news on Sudden cardiac death

News trends on Sudden cardiac death

Commentary

Blogs on Sudden cardiac death

Definitions

Definitions of Sudden cardiac death

Patient Resources / Community

Patient resources on Sudden cardiac death

Discussion groups on Sudden cardiac death

Patient Handouts on Sudden cardiac death

Directions to Hospitals Treating Sudden cardiac death

Risk calculators and risk factors for Sudden cardiac death

Healthcare Provider Resources

Symptoms of Sudden cardiac death

Causes & Risk Factors for Sudden cardiac death

Diagnostic studies for Sudden cardiac death

Treatment of Sudden cardiac death

Continuing Medical Education (CME)

CME Programs on Sudden cardiac death

International

Sudden cardiac death en Espanol

Sudden cardiac death en Francais

Business

Sudden cardiac death in the Marketplace

Patents on Sudden cardiac death

Experimental / Informatics

List of terms related to Sudden cardiac death

Cardiology Network

Discuss Sudden cardiac death further in the WikiDoc Cardiology Network
Adult Congenital
Biomarkers
Cardiac Rehabilitation
Congestive Heart Failure
CT Angiography
Echocardiography
Electrophysiology
Cardiology General
Genetics
Health Economics
Hypertension
Interventional Cardiology
MRI
Nuclear Cardiology
Peripheral Arterial Disease
Prevention
Public Policy
Pulmonary Embolism
Stable Angina
Valvular Heart Disease
Vascular Medicine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Associate Editor-In-Chief: M.Umer Tariq [3]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [4] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

The term sudden cardiac death refers to natural death from cardiac causes, heralded by abrupt loss of consciousness within one hour of the onset of acute symptoms.[1] Other forms of sudden death may be noncardiac in origin and are therefore termed sudden death rather than sudden cardiac death. Examples of this include respiratory arrest (such as due to airway obstruction, which may be seen in cases of choking or asphyxiation), toxicity or poisoning, anaphylaxis, or trauma.[2]

It is important to make a distinction between this term and the related term cardiac arrest, which refers to cessation of cardiac pump function which may be reversible (i.e., may not be fatal). The phrase Sudden Cardiac Death is a public health concept incorporating the features of natural, rapid, and unexpected. It does not specifically refer to the mechanism or cause of death. Although the most frequent underlying cause of Sudden Cardiac Death is Coronary Artery Disease, other categories of causes are listed below.

Complete Differential Diagnosis for Sudden Cardiac Death


Complete Differential Diagnosis for Sudden Non-Cardiac Death


Complete Differential Diagnosis of the Causes of Sudden Death Including Sudden Cardiac Death


Complete Differential Diagnosis of the Causes of Sudden Death Including Sudden Cardiac Death

(By organ system)

Cardiovascular

Amyloid cardiopathy, Congestive heart failure, Ventricular rupture,

* Ischemic

Hypoxia, Coronary thrombosis, Coronary vasospasm, Coronary artery aneurysm, Prinzmetal's variant angina ,

* Pericardial

Cardiac tamponade,

* Myocardial

Asymmetric septal hypertrophy , ST Elevation Myocardial Infarction, Dilated cardiomyopathy, Giant cell myocarditis , Hypertrophic cardiomyopathy, Kugel-Stoloff syndrome , Myocardial infarction, Myocarditis, Rupture of the papillary muscles,

* Endocardial/Valvular

Mitral valve prolapse, Valvular Heart Disease,

* Conduction/Arrhythmia

Arrhythmogenic right ventricular cardiomyopathy, Arrhythmogenic right ventricular dysplasia, Brugada syndrome, Complete atrioventricular block, Jervell and Lange-Nielsen Syndrome, Prolonged Q-T Interval Syndrome, Multifocal ventricular premature beats , Naxos disease , Romano-Ward syndrome , Sick sinus syndrome, Short QT syndrome , Sinus node disease, Stokes-Adams Syndrome, Sudden Arrhythmia Death Syndrome, Wolf-Parkinson-White syndrome,

* Vascular

Acute aortic insufficiency, Acute coronary syndrome, Aortic dissection, Aortic stenosis, Aorto-ventricular tunnel, Arteritis, Coronary artery disease, Coronary arteries - congenital malformation , Ruptured abdominal aortic aneurysm,

Congenital/Developmental

Congenital heart disease, Congenital heart block , Congenital Long QT syndrome, Noncompaction Cardiomyopathy, Sudden Infant Death Syndrome, Uhl anomaly

Chemical / poisoning

Snake bite

Dermatologic No underlying causes
Drug Side Effect

Drug allergy, Drug overdose

Ear Nose Throat No underlying causes
Endocrine

Catecholaminergic polymorphic ventricular tachycardia, Diabetic ketoacidosis - typically from undiagnosed diabetes, Thyrotoxicosis,

Environmental Hypothermia,
Gastroenterologic

Appendicitis, Gastrointestinal bleeding, Retroperitoneal bleed,

Genetic

Brugada syndrome, 3-methylglutaconic aciduria, type 1, Familial dilated cardiomyopathy , Familial hypertrophic cardiomyopathy 1, Hyperbilirubinemia transient, familial neonatal, Marfan syndrome , Timothy syndrome

Hematologic No underlying causes
Iatrogenic Transfusion reaction
Infectious Disease

Flu mainly in the elderly, infants, infirm or chronically ill, Neurocysticercosis

Musculoskeletal / Ortho No underlying causes
Neurologic

Apoplexy, Encephalitis, Intracranial hemmorhage, Meningitis, Stroke, Subarachnoid hemorrhage,

Nutritional / Metabolic

3-methylglutaconic aciduria, type 1, Alpha-ketoglutarate dehydrogenase deficiency , Food allergy

Obstetric/Gynecologic

Amniotic fluid syndrome , Childbirth hemorrhage,

Oncologic

Atrial myxoma, familial

Opthalmologic No underlying causes
Overdose / Toxicity

Opioid overdose , Oxycontin overdose, Pain killer overdose , Sleeping pill overdose

Psychiatric No underlying causes
Pulmonary

Hypercapnia, Pickwickian Syndrome, Pulmonary embolism, Tension pneumothorax, Status asthmaticus

Renal / Electrolyte

Hypercalcemia, Hypokalemia, Hyperkalemia,

Rheum / Immune / Allergy

Amyloidosis, Anaphylaxis, Myasthenia gravis, Sarcoidosis,

Sexual No underlying causes
Trauma

Commotio cordis, Homicide, Motor Vehicle accident

Urologic No underlying causes
Miscellaneous

Shock, Asphyxia, Insect bite Sepsis syndrome, Shock

Prevention of Sudden Cardiac Death

ACC / AHA Guidelines- Recommendations for Implantable Cardioverter Defibrillators (DO NOT EDIT) [3]

Class I

1. ICD therapy is indicated in patients who are survivors of cardiac arrest due to VF or hemodynamically unstable sustained VT after evaluation to define the cause of the event and to exclude any completely reversible causes. (Level of Evidence: A)

2. ICD therapy is indicated in patients with structural heart disease and spontaneous sustained VT, whether hemodynamically stable or unstable. (Level of Evidence: B)

3. ICD therapy is indicated in patients with syncope of undetermined origin with clinically relevant, hemodynamically significant sustained VT or VF induced at electrophysiological study. (Level of Evidence: B)

4. ICD therapy is indicated in patients with LVEF less than 35% due to prior MI who are at least 40 days post-MI and are in NYHA functional Class II or III. (Level of Evidence: A)

5. ICD therapy is indicated in patients with nonischemic DCM who have an LVEF less than or equal to 35% and who are in NYHA functional Class II or III. (Level of Evidence: B)

6. ICD therapy is indicated in patients with LV dysfunction due to prior MI who are at least 40 days post-MI, have an LVEF less than 30%, and are in NYHA functional Class I. (Level of Evidence: A)

7. ICD therapy is indicated in patients with nonsustained VT due to prior MI, LVEF less than 40%, and inducible VF or sustained VT at electrophysiological study. (Level of Evidence: B)

Class IIa

1. ICD implantation is reasonable for patients with unexplained syncope, significant LV dysfunction, and nonischemic DCM. (Level of Evidence: C)

2. ICD implantation is reasonable for patients with sustained VT and normal or near-normal ventricular function. (Level of Evidence: C)

3. ICD implantation is reasonable for patients with HCM who have 1 or more major{dagger} risk factors for SCD. (Level of Evidence: C)

4. ICD implantation is reasonable for the prevention of SCD in patients with ARVD/C who have 1 or more risk factors for SCD. (Level of Evidence: C)

5. ICD implantation is reasonable to reduce SCD in patients with long-QT syndrome who are experiencing syncope and/or VT while receiving beta blockers. (Level of Evidence: B)

6. ICD implantation is reasonable for non hospitalized patients awaiting transplantation. (Level of Evidence: C)

7. ICD implantation is reasonable for patients with Brugada syndrome who have had syncope. (Level of Evidence: C)

8. ICD implantation is reasonable for patients with Brugada syndrome who have documented VT that has not resulted in cardiac arrest. (Level of Evidence: C)

9. ICD implantation is reasonable for patients with catecholaminergic polymorphic VT who have syncope and/or documented sustained VT while receiving beta blockers. (Level of Evidence: C)

10. ICD implantation is reasonable for patients with cardiac sarcoidosis, giant cell myocarditis, or Chagas disease. (Level of Evidence: C)

Class IIb

1. ICD therapy may be considered in patients with nonischemic heart disease who have an LVEF of less than or equal to 35% and who are in NYHA functional Class I. (Level of Evidence: C)

2. ICD therapy may be considered for patients with long-QT syndrome and risk factors for SCD. (Level of Evidence: B)

3. ICD therapy may be considered in patients with syncope and advanced structural heart disease in whom thorough invasive and noninvasive investigations have failed to define a cause. (Level of Evidence: C)

4. ICD therapy may be considered in patients with a familial cardiomyopathy associated with sudden death. (Level of Evidence: C)

5. ICD therapy may be considered in patients with LV noncompaction. (Level of Evidence: C)

Class III

1. ICD therapy is not indicated for patients who do not have a reasonable expectation of survival with an acceptable functional status for at least 1 year, even if they meet ICD implantation criteria specified in the Class I, IIa, and IIb recommendations above. (Level of Evidence: C)

2. ICD therapy is not indicated for patients with incessant VT or VF. (Level of Evidence: C)

3. ICD therapy is not indicated in patients with significant psychiatric illnesses that may be aggravated by device implantation or that may preclude systematic follow-up. (Level of Evidence: C)

4. ICD therapy is not indicated for NYHA Class IV patients with drug-refractory congestive heart failure who are not candidates for cardiac transplantation or CRT-D. (Level of Evidence: C)

5. ICD therapy is not indicated for syncope of undetermined cause in a patient without inducible ventricular tachyarrhythmias and without structural heart disease. (Level of Evidence: C)

6. ICD therapy is not indicated when VF or VT is amenable to surgical or catheter ablation (e.g., atrial arrhythmias associated with the Wolff-Parkinson-White syndrome, RV or LV outflow tract VT, idiopathic VT, or fascicular VT in the absence of structural heart disease). (Level of Evidence: C)

7. ICD therapy is not indicated for patients with ventricular tachyarrhythmias due to a completely reversible disorder in the absence of structural heart disease (e.g., electrolyte imbalance, drugs, or trauma). (Level of Evidence: B)

ACC / AHA Guidelines- Recommendations for Implantable Cardioverter-Defibrillators in Pediatric Patients and Patients With Congenital Heart Disease (DO NOT EDIT) [3]

Class I

1. ICD implantation is indicated in the survivor of cardiac arrest after evaluation to define the cause of the event and to exclude any reversible causes. (Level of Evidence: B)

2. ICD implantation is indicated for patients with symptomatic sustained VT in association with congenital heart disease who have undergone hemodynamic and electrophysiological evaluation. Catheter ablation or surgical repair may offer possible alternatives in carefully selected patients. (Level of Evidence: C)

Class IIa

1. ICD implantation is reasonable for patients with congenital heart disease with recurrent syncope of undetermined origin in the presence of either ventricular dysfunction or inducible ventricular arrhythmias at electrophysiological study. (Level of Evidence: B)

Class IIb

1. ICD implantation may be considered for patients with recurrent syncope associated with complex congenital heart disease and advanced systemic ventricular dysfunction when thorough invasive and noninvasive investigations have failed to define a cause. (Level of Evidence: C)

Class III

1. All Class III recommendations found in Section 3, "Indications for Implantable Cardioverter-Defibrillator Therapy," apply to pediatric patients and patients with congenital heart disease, and ICD implantation is not indicated in these patient populations. (Level of Evidence: C)

Sources

  • ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons [3]
  • ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines) [4]
  • ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive Summary--a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation) [5]

References

  1. Myerburg, Robert J. "Cardiac Arrest and Sudden Cardiac Death" in Heart Disease: A Textbook of Cardiovascular Medicine, 7th edition. Philadelphia: WB Saunders, 2005.
  2. Sudden Unexpected Death: Causes and Contributing Factors on poptop.hypermart.net.
  3. 3.0 3.1 3.2 Epstein AE, DiMarco JP, Ellenbogen KA; et al. (2008). "ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons". Circulation. 117 (21): e350–408. PMID 18483207. Text "doi:10.1161/CIRCUALTIONAHA.108.189742 " ignored (help); Unknown parameter |month= ignored (help)
  4. Gregoratos G, Abrams J, Epstein AE; et al. (2002). "ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines)". Circulation. 106 (16): 2145–61. PMID 12379588. Text "doi:10.1161/01.CIR.0000035996.46455.09 " ignored (help); Unknown parameter |month= ignored (help)
  5. Gregoratos G, Cheitlin MD, Conill A; et al. (1998). "ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive Summary--a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation)". Circulation. 97 (13): 1325–35. PMID 9570207. Unknown parameter |month= ignored (help)

External links

Additional resources

Template:SIB fi:Äkkikuolema


Template:WikiDoc Sources